Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Karadogan, E.
17  Ergebnisse:
Personensuche X
?
1

Numerical modeling of the Lower Mississippi River-influence..:

, In: OCEANS 2009,
Karadogan, E. ; Willson, C. S. ; Berger, C. R. - p. None , 2009
Link: https://doi.org/10.23919..
 
?
2

Nivolumab for relapsed or refractory Hodgkin lymphoma: Expe..:

Ferhanoglu, B. ; Bekoz, H. ; Karadurmus, N....
Hematological Oncology.  35 (2017)  S2 - p. 321-323 , 2017
Link: https://doi.org/10.1002/..
 
?
3

Development of a new and simplified procedure for the exper..:

Karadogan, C. ; Tamer, M.E.
CIRP Annals.  64 (2015)  1 - p. 265-268 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Salihoglu, A. ; Elverdi, T. ; Karadogan, I....
Annals of Hematology.  94 (2014)  3 - p. 415-420 , 2014
Link: https://doi.org/10.1007/..
 
?
5

Effect of irrigation applied at different growth stages and..:

Günel, E. ; Karadoĝan, T.
Potato Research.  41 (1998)  1 - p. 9-19 , 1998
Link: https://doi.org/10.1007/..
 
?
6

An Algorithm to Justify the Design of Single Story Precast ..:

, In: Perspectives on European Earthquake Engineering and Seismology; Geotechnical, Geological and Earthquake Engineering,
Karadoğan, H. F. ; Bal, I. E. ; Yüksel, E.... - p. 207-226 , 2015
Link: https://doi.org/10.1007/..
 
?
7

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPE..:

Ferhanoglu, B ; Bekoz, H ; Karadurmus, N...
Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı.  , 2017
Link: https://hdl.handle.net/1..
 
?
8

Nivolumab for relapsed or refractory Hodgkin lymphoma: real..:

Bekoz, H ; Karadurmus, N ; Paydas, S...
10.1093/annonc/mdx341.  , 2017
Link: https://hdl.handle.net/1..
 
?
9

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPE..:

Bekoz, H ; Kaynar, L ; Karadogan, I...
Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı.  , 2017
Link: https://hdl.handle.net/1..
 
?
10

Nivolumab For Relapsed Or Refractory Hodgkin Lymphoma: Real..:

Bekoz, H ; Karadurmus, N ; Paydas, S...
10.1093/annonc/mdx341.  , 2017
Link: http://hdl.handle.net/11..
 
?
11

Nivolumab for relapsed or refractory Hodgkin lymphoma: real..:

Karadurmus, N ; Bekoz, H ; Paydas, S...
Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı.  , 2017
Link: https://hdl.handle.net/1..
 
?
12

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Salihoglu A ; Elverdi T ; Karadogan I...
10.1007/s00277-014-2215-9.  , 2015
Link: https://hdl.handle.net/2..
 
?
13

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Yegin, Z. A ; KARADURMUS, N ; SUCAK, G...
ddef9b56-56c2-414d-8f79-575567544c44.  , 2015
Link: https://doi.org/10.1007/..
 
?
14

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Ferhanoglu, B ; Baslar, Z ; PAYDAŞ, SAİME...
ddef9b56-56c2-414d-8f79-575567544c44.  , 2015
Link: https://doi.org/10.1007/..
 
?
15

Brentuximab Vedotin For Relapsed or Refractory Hodgkin Lymp..:

Salihoglu, A ; Elverdi, T ; Karadogan, I...
10.1007/s00277-014-2215-9.  , 2015
Link: http://hdl.handle.net/11..
 
1-15